Beyond phase 3 registration trials: defining safety for triple therapy with protease inhibitors in cirrhosis
- PMID: 24334256
- DOI: 10.1136/gutjnl-2013-306480
Beyond phase 3 registration trials: defining safety for triple therapy with protease inhibitors in cirrhosis
Keywords: ANTIVIRAL THERAPY; CIRRHOSIS; HEPATITIS C.
Comment on
-
Safety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis C.Gut. 2014 Jul;63(7):1150-8. doi: 10.1136/gutjnl-2013-305667. Epub 2013 Nov 7. Gut. 2014. PMID: 24201995 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical